Correction to: "GLP-1 Receptor Agonists and SGLT-2 Inhibitors as Adjuncts to Insulin in Type 1 Diabetes: Benefits and Concerns". . J Clin Endocrinol Metab 2023 Jan 19:dgad022. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Correction to: "GLP-1 Receptor Agonists and SGLT-2 Inhibitors as Adjuncts to Insulin in Type 1 Diabetes: Benefits and Concerns". J Clin Endocrinol Metab 2023 Jan 19:dgad022. doi: 10.1210.
PMID: 36656760